Bekas, N.; Samiotaki, M.; Papathanasiou, M.; Mokos, P.; Pseftogas, A.; Xanthopoulos, K.; Thanos, D.; Mosialos, G.; Dafou, D.
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency. Cancers 2023, 15, 4997.
https://doi.org/10.3390/cancers15204997
AMA Style
Bekas N, Samiotaki M, Papathanasiou M, Mokos P, Pseftogas A, Xanthopoulos K, Thanos D, Mosialos G, Dafou D.
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency. Cancers. 2023; 15(20):4997.
https://doi.org/10.3390/cancers15204997
Chicago/Turabian Style
Bekas, Nikolaos, Martina Samiotaki, Maria Papathanasiou, Panagiotis Mokos, Athanasios Pseftogas, Konstantinos Xanthopoulos, Dimitris Thanos, George Mosialos, and Dimitra Dafou.
2023. "Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency" Cancers 15, no. 20: 4997.
https://doi.org/10.3390/cancers15204997
APA Style
Bekas, N., Samiotaki, M., Papathanasiou, M., Mokos, P., Pseftogas, A., Xanthopoulos, K., Thanos, D., Mosialos, G., & Dafou, D.
(2023). Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency. Cancers, 15(20), 4997.
https://doi.org/10.3390/cancers15204997